Turkey | Not Specified
1
Before (2014) vs after (2018) incentive tools for reducing AMU of critically important antimicrobials, i.e. prohibition on discounts, rebates, reductions (in effect Jan 1 2015) & ban of preventive CIA use (in effect 2016). High level resistance (> 1 ug/mL
Resistance | Microbe | Outcome | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ciprofloxacin / | Escherichia coli |
|